Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Codexis Inc

0I0X
Current price
2.67 USD -0.092 USD (-3.34%)
Last closed 2.73 USD
ISIN US1920051067
Sector Healthcare
Industry Biotechnology
Exchange London Exchange
Capitalization 194 341 072 USD
Yield for 12 month +29.38 %
1Y
3Y
5Y
10Y
15Y
0I0X
21.11.2021 - 28.11.2021

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California. Address: 200 Penobscot Drive, Redwood City, CA, United States, 94063

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6.86 USD

P/E ratio

Dividend Yield

Current Year

+70 143 000 USD

Last Year

+138 590 000 USD

Current Quarter

+7 979 000 USD

Last Quarter

+17 073 000 USD

Current Year

+51 816 000 USD

Last Year

+100 557 000 USD

Current Quarter

+3 278 000 USD

Last Quarter

+10 966 000 USD

Key Figures 0I0X

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -48 022 000 USD
Operating Margin TTM -282.83 %
PE Ratio
Return On Assets TTM -19.6 %
PEG Ratio -1.16
Return On Equity TTM -82.29 %
Wall Street Target Price 6.86 USD
Revenue TTM 60 890 000 USD
Book Value 0.87 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -62.6 %
Dividend Yield
Gross Profit TTM 20 458 000 USD
Earnings per share -1.1 USD
Diluted Eps TTM -1.1 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -125.41 %

Dividend Analytics 0I0X

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 0I0X

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 0I0X

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 138.8889
Enterprise Value Revenue 2.6881
Price Sales TTM 3.1917
Enterprise Value EBITDA -10.672
Price Book MRQ 3.1627

Financials 0I0X

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 0I0X

For 52 weeks

1.45 USD 4.91 USD
50 Day MA 3.14 USD
Shares Short Prior Month 2 032 230
200 Day MA 3.08 USD
Short Ratio 4.32
Shares Short 1 958 807
Short Percent 3.14 %

Dynamics of changes in the value of assets

R

RNR

254.20 USD Renaissancere Holdings Ltd -0.46 (-0.18%)
Detailed analytics
E

EXK

59.32 EUR EXACT SCIENCES +1.62 (+2.54%)
Detailed analytics
C

CLH

101.85 EUR CARDINAL HEALTH -1.38 (-1.21%)
Detailed analytics
0

0HAN

31.13 EUR Bouygues SA -0.55 (-1.57%)
Detailed analytics
R

RIVN

13.72 USD Rivian Automotive Inc -0.05 (-0.36%)
Detailed analytics